about
Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplifi...
Read More
2.60
1.20
(85.71%)
65.2M
XNAS Volume
High volume+gain today
XNAS 23 Jun, 2026 5:30 PM (EDT)
Board Meeting
The latest board meeting for Boundless Bio Inc took place on 23 Jun 2026, for the purpose of Boundless Bio Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
Boundless Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..